Inventor · disambiguated record
Zelig Eshhar
Also filed as: ESHHAR ZELIG
13 granted patents·9 pending applications·1,345 citations·filing 1991–2024
93Inventor score
Files withYEDA RES & DEV12ESHHAR ZELIG3MEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT3UNIV RAMOT2BIOSENSOR APPLIC SWEDEN AB1
Top patents by PatentIndex Score
22 records- 0196US7741465B1Chimeric receptor genes and cells transformed therewithESHHAR ZELIG·Filed 1993·Granted Jun 22, 2010·598 cites·20 claims
- 0296US5906936AEndowing lymphocytes with antibody specificityYEDA RES & DEV·Filed 1993·Granted May 25, 1999·271 cites·33 claims
- 0395US8211422B2Chimeric receptor genes and cells transformed therewithESHHAR ZELIG·Filed 1995·Granted Jul 3, 2012·240 cites·30 claims
- 0495US5912172AEndowing lymphocytes with antibody specificityYEDA RES & DEV·Filed 1995·Granted Jun 15, 1999·181 cites·41 claims
- 0589US9623049B2Immunotherapy using redirected allogeneic cellsYEDA RES & DEV·Filed 2012·Granted Apr 18, 2017·12 cites·15 claims
- 0676US7135295B1Detection of small molecules by use of a piezoelectric sensorBIOSENSOR APPLIC SWEDEN AB·Filed 2000·Granted Nov 14, 2006·13 cites·61 claims
- 0771US9346854B2Anti-inflammatory peptides and use thereofYEDA RES & DEV·Filed 2014·Granted May 24, 2016·2 cites·14 claims
- 0868US2024139247A1T-cells comprising anti-cd38 and anti-cd138 chimeric antigen receptors and uses thereofMEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT·Filed 2024·Application pending·0 cites
- 0965US11326147B2Redirected, genetically-engineered T regulatory cells and their use in suppression of autoimmune and inflammatory diseaseYEDA RES & DEV·Filed 2019·Granted May 10, 2022·0 cites·17 claims
- 1065US6090923AMurine monoclonal antibody binding TNFαYEDA RES & DEV·Filed 1991·Granted Jul 18, 2000·26 cites·12 claims
- 1161US11944644B2T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereofMEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT·Filed 2018·Granted Apr 2, 2024·0 cites·19 claims
- 1256US2010135974A1Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory diseaseYEDA RES & DEV·Filed 2008·Application pending·0 cites
- 1354US2023321235A1Veto car-t cellsYEDA RES & DEV·Filed 2021·Application pending·0 cites
- 1451US2017216356A1Immunotherapy using redirected allogeneic cellsYEDA RES & DEV·Filed 2017·Application pending·0 cites
- 1550US2024216510A1Chimeric antigen receptors to sialyl-tn glycan antigenUNIV RAMOT·Filed 2022·Application pending·0 cites
- 1649US2012093842A1Chimeric receptor genes and cells transformed therewithESHHAR ZELIG·Filed 2011·Application pending·0 cites
- 1747US2022204928A1Extracellular vesicles derived from activated car-t cellsYEDA RES & DEV·Filed 2020·Application pending·0 cites
- 1845US11932871B2Methods of culturing t cells and uses of sameYEDA RES & DEV·Filed 2018·Granted Mar 19, 2024·0 cites·10 claims
- 1944US2023058044A1Chimeric antigen receptor to carbohydrate antigensUNIV RAMOT·Filed 2020·Application pending·0 cites
- 2039US2020215112A1Chimeric antigen receptor for her2/neu and t-cells expressing sameCTG PHARMA LTD·Filed 2018·Application pending·0 cites
- 2137US12139522B2T-cells comprising two different chimeric antigen receptors and uses thereofMEDICAL RES INFRASTRUCTURE & HEALTH SERVICES FUND TEL AVIV MEDICAL CT·Filed 2018·Granted Nov 12, 2024·0 cites·18 claims
- 2230US5766861AMethod for screening catalytic non-enzyme polypeptides and proteinsYEDA RES & DEV·Filed 1994·Granted Jun 16, 1998·2 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Zelig Eshhar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →